McPherson’s Flags FY27 Execution Challenge as AGM Resolutions Pass
MCP: $0.130 -5.45% · MC: $20M
McPherson’s said its FY26 transformation had delivered cost savings and broader pharmacy distribution, but sales and earnings fell short of expectations; it reported revenue of $118 million, underlying EBITDA of $4 million and a statutory net loss of $20 million. For FY27, the board says priorities include restoring growth, improving earnings and appointing a new CEO, while expecting working-capital investment to unwind progressively and release cash. Shareholders passed resolutions electing John Batistich and adopting the remuneration report; a proposed performance-rights resolution for outgoing CEO Brett Charlton was withdrawn.

Comments